E. Shyam P. Reddy/LinkedIn
Jun 26, 2025, 17:54
E. Shyam P. Reddy: Obesity Drugs Might also Tackle Migraine
E. Shyam P. Reddy, Professor and Director of the Cancer Biology Program at Morehouse School of Medicine, shared a post on LinkedIn:
“Obesity drugs might also tackle migraine
The weight-loss drug liraglutide – a GLP-1 receptor agonist similar to Ozempic – could also help to treat migraines. In a small study, liraglutide almost halved the mean number of days per month people with obesity and chronic migraine experienced a headache.
The work didn’t include a control group, so some of the benefit could have been down to the placebo effect, says headache-disorder specialist Lanfranco Pellesi. Still, the results are promising enough to justify a randomized controlled trial to test the effect more thoroughly, he says.”
More posts featuring E. Shyam P. Reddy.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 26, 2025, 17:54
Jun 26, 2025, 17:47
Jun 26, 2025, 17:29
Jun 26, 2025, 14:50
Jun 26, 2025, 14:20